Significant delay in the introduction of systemic treatment of moderate to severe psoriasis: a prospective multicentre observational study in outpatients from hospital dermatology departments in France

A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study

(2010) D. Thaçi et al.   BRITISH JOURNAL OF DERMATOLOGY

Alexithymia is associated with glycaemic control of children with type 1 diabetes

(2010) M. Housiaux et al.   DIABETES & METABOLISM

A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis

(2010) Yves Poulin et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

(2010) Richard G. Langley et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists

(2010) C Paul et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Unconventional medicine in dermatology outpatients in Turkey

(2009) Müzeyyen Gönül et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

The Impact of Alexithymia on Asthma Patient Management and Communication with Health Care Providers: A Pilot Study

(2009) Kelly Chugg et al.   JOURNAL OF ASTHMA

Moderate to severe psoriasis: from topical to biological treatment

(2009) I Gardinal et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Alexithymie et psoriasis : étude cas–témoin à propos de 53 patients

(2008) J. Masmoudi et al.   ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE

Increasing use of more potent treatments for psoriasis

(2008) Lindsay C. Strowd et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

(2007) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY